Background
Leukemoid reaction refers to a reactive leukocytosis, which has been described in response to inflammation, severe or disseminated infection, tissue destruction or other marrow stimulants. Leukemoid reaction is a sign for poor prognosis in solid tumors and so is sarcomatoid renal cell carcinoma (SRCC) when compared to more differentiated histologies. SRCC is a rare but very aggressive variant of renal cell carcinoma (RCC) which used to be thought of as a primary renal sarcoma. Since these tumors co-express both epithelial and stromal markers, they are now believed to represent a form of dedifferentiated carcinoma. As SRCC is highly resistant to chemotherapy and easily metastases, many patients died shortly after diagnosis. Leukemoid reactions have been described mainly in association with lung, gastrointestinal, bladder and head and neck cancers, but have rarely been described in association with SRCC. To our knowledge, these are the first two cases report to do so. The characteristics of both patients are described in Tables
1 and
2.
Table 1
Baseline and clinical characteristics (Case 1)
Age (year) | 36 |
Sex | female |
BMI (Kg/m2) | 22.5 |
Tumor size (cm) | 10 |
TNM stage | |
T | T2 |
N | N1 |
M | M0 |
Stage | III |
Whole blood count | |
Red blood cell | 3.43*10^12/L |
Hb | 102 g/L |
Platelet | 110*10^9/L |
White blood cell | 47.2*10^9/L |
NEUT% | 89.2 |
Lactate dehydrogenase | 1075 U/L |
Alkaline phosphatse | 434 U/L |
Operation | nephrectomy |
| free margins with 2/7 positive lymph nodes in posterior peritoneum |
Immunohistology | |
| CAM5.2(+)CD10(+)CD15(+)CEA(-)CK20(-)CK7(-)RCC(-)VIM(+) |
Reason for death | multiple organ failure |
Table 2
Baseline demographic and clinical characteristics (Case 2)
Age (year) | 56 |
Sex | male |
BMI (Kg/m2) | 24.5 |
Tumor size (cm) | 10 |
TNM stage | |
T | T2 |
N | N0 |
M | M0 |
Stage | II |
Whole blood count | |
Red blood cell | 3.23*10^12/L |
Hb | 98 g/L |
Platelet | 258*10^9/L |
White blood cell | 30.2*10^9/L |
NEUT% | 91.3 |
Lactate dehydrogenase | 558 U/L |
Alkaline phosphatse | 289U/L |
Operation | nephrectomy |
| free margins with 0/5 negative lymph nodes in posterior peritoneum |
Immunhistology | |
| CAM5.2(+)EMA(-)SMA(+)DES(-)CgA(-)S-100(-)CK20(-)CK7(-)RCC(-)VIM(+) |
Reason for death | multiple organ failure |
Conclusions
Leukemoid reaction is firstly defined by Krumbhaar to describe a phenomenon concerning patients with blood findings that resembling some type of leukemia, but in whom leukemia is not confirmed through the subsequent course of the illness [
1]. There is also a more restrictive definition in which the WBC count exceeding 40.000/ul is associated with a cause outside the bone marrow, or a certain proportion of blast cells are present in the blood [
2]. Leukemoid reactions are probably caused by mechanical stimuli on bone marrow, resulting from bone metastases. They may also be caused by humoral stimuli resulting from neosynthesized blastic factors, or factors released from the foci of tumor necrosis.
Leukemoid reactions in carcinoma have often been described in association with carcinomas of the stomach, colon, liver, gall bladder, pancreas, lung, bladder, bone, and thyroid gland [
3‐
8]. They have been reported in association with renal cell carcinoma RCC [
9], but not with SRCC. To our knowledge, it is the first time that a leukemoid reaction has been reported in association with SRCC.
Both of the two patients had fever during the treatment and observation process. However, fever is an integral component of a leukemoid reaction, often associated with other paraneoplastic syndromes, resulting from either a release of endogenous pyrogens or due to necrotic-inflammatory phenomena of the tumor [
10]. Standard antipyretic drugs and antibiotics are usually ineffective. Interleukin I (IL-1) and tumor necrotic factor (alpha) centrally acting on the thermoregulatory center of the hypothalamus are the major endogenous pyrogens [
11,
12].
A granulocyte colony-stimulating factor (G-CSF) driven reaction is usually seen in advanced local or metastatic disease. It is thought to be associated with tumor progression and necrosis. With the function of this auto–production hematopoietic growth factor, precursor cells in the bone marrow are stimulated to proliferation and maturation into fully differentiated neutrophils [
13,
14]. Generally, the WBC count will decrease to the normal range if the cause of a leukemoid reaction is eliminated. However, in these two patients, tumor resection did not result in the return of the WBC count. The final WBC count before death was extremely high.
Sarcomatoid differentiation of RCC occurs in all histologic subtypes of RCC, with the incidence ranging from 1.2% to 23.6% [
15]. It is uniformly associated with a poor prognosis, with a median survival ranging from 2 to 9 months [
15‐
17]. Surgery, alone, is often inadequate to cure patients, although there is no proven rule for adjuvant therapy. We performed a review of SRCC treatment these 10 years, finding that there was a case report indicating that sunitinib could be helpful for advanced SRCC [
18]. Whether the application of tyrosin-kinase inhibitors such as sunitinib would be beneficial for a leukemoid reaction in SRCC is unclear, but worth trying.
These two cases indicate that leukemoid reaction may be a predictor of prognosis in patients with SRCC. Due to most of the patients with a malignant leukemoid reaction having a poor prognosis, it should always keep in mind that the sarcomatoid possibility of the tumor origin when there is an unknown etiology of leukecytosis, especially when infection is not likely. Clearly, more data and evidence are still needed to carry out extensive hematological diagnostic tests in order to distinguish the cause of the leukemoid reaction which would make it easier to find an effective adjuvant therapy.
Competing interest
The authors declare that there is no conflict of interest.
Authors’ contributions
WH: conception and design of the study, acquisition of data, and interpretation of data. WHFW: drafting the manuscript and revising it critically for important content. YL: drafting the manuscript and revising it critically for important content. FD: finished partial manuscript and translation. ZY: conception and coordination of the study. All authors have read and approved the final manuscript.